Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3003090313;90314;90315 chr2:178552812;178552811;178552810chr2:179417539;179417538;179417537
N2AB2838985390;85391;85392 chr2:178552812;178552811;178552810chr2:179417539;179417538;179417537
N2A2746282609;82610;82611 chr2:178552812;178552811;178552810chr2:179417539;179417538;179417537
N2B2096563118;63119;63120 chr2:178552812;178552811;178552810chr2:179417539;179417538;179417537
Novex-12109063493;63494;63495 chr2:178552812;178552811;178552810chr2:179417539;179417538;179417537
Novex-22115763694;63695;63696 chr2:178552812;178552811;178552810chr2:179417539;179417538;179417537
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTA
  • RefSeq wild type template codon: CAT
  • Domain: Fn3-107
  • Domain position: 1
  • Structural Position: 1
  • Q(SASA): 0.5205
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I rs1167897212 -0.34 0.006 N 0.158 0.123 0.354183961838 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 0 None 0 None 0 8.88E-06 0
V/I rs1167897212 -0.34 0.006 N 0.158 0.123 0.354183961838 gnomAD-4.0.0 1.20033E-06 None None None None I None 0 0 None 0 0 None 0 0 1.31251E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.192 likely_benign 0.1712 benign -0.777 Destabilizing 0.435 N 0.319 neutral N 0.480112415 None None I
V/C 0.7655 likely_pathogenic 0.7456 pathogenic -0.721 Destabilizing 0.995 D 0.306 neutral None None None None I
V/D 0.5214 ambiguous 0.4564 ambiguous -0.378 Destabilizing 0.946 D 0.474 neutral None None None None I
V/E 0.3233 likely_benign 0.2908 benign -0.488 Destabilizing 0.93 D 0.431 neutral N 0.464327666 None None I
V/F 0.2449 likely_benign 0.2275 benign -0.973 Destabilizing 0.897 D 0.415 neutral None None None None I
V/G 0.3074 likely_benign 0.2669 benign -0.925 Destabilizing 0.791 D 0.453 neutral N 0.487547255 None None I
V/H 0.6713 likely_pathogenic 0.6376 pathogenic -0.439 Destabilizing 0.995 D 0.421 neutral None None None None I
V/I 0.0802 likely_benign 0.0776 benign -0.531 Destabilizing 0.006 N 0.158 neutral N 0.52153775 None None I
V/K 0.2829 likely_benign 0.2705 benign -0.472 Destabilizing 0.946 D 0.423 neutral None None None None I
V/L 0.2499 likely_benign 0.2278 benign -0.531 Destabilizing 0.144 N 0.281 neutral N 0.466654616 None None I
V/M 0.1592 likely_benign 0.1447 benign -0.384 Destabilizing 0.182 N 0.28 neutral None None None None I
V/N 0.351 ambiguous 0.3052 benign -0.223 Destabilizing 0.946 D 0.475 neutral None None None None I
V/P 0.3028 likely_benign 0.2964 benign -0.578 Destabilizing 0.982 D 0.402 neutral None None None None I
V/Q 0.3265 likely_benign 0.3081 benign -0.522 Destabilizing 0.946 D 0.465 neutral None None None None I
V/R 0.2897 likely_benign 0.2802 benign 0.073 Stabilizing 0.946 D 0.512 neutral None None None None I
V/S 0.2822 likely_benign 0.2458 benign -0.656 Destabilizing 0.553 D 0.357 neutral None None None None I
V/T 0.1982 likely_benign 0.1752 benign -0.667 Destabilizing 0.014 N 0.059 neutral None None None None I
V/W 0.8819 likely_pathogenic 0.8618 pathogenic -0.996 Destabilizing 0.995 D 0.531 neutral None None None None I
V/Y 0.6102 likely_pathogenic 0.5817 pathogenic -0.697 Destabilizing 0.982 D 0.415 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.